USDM
LIVE

Serial Number

90026935

Owner

US Data Management, LLC

Attorney

Darren B. Cohen

First Use Date

Nov 5, 2013

Filing Date

Jun 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

USDM Trademark

Serial Number: 90026935 • Registration: 6791916

USDM is a trademark filed by US Data Management, LLC on June 29, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

US Data Management, LLC (14 trademarks)

535 Chapala Street
Santa Barbara, CA 93101

Entity Type: 16

Trademark Details

Filing Date

June 29, 2020

Registration Date

July 19, 2022

First Use Anywhere

November 5, 2013

First Use in Commerce

November 5, 2013

Published for Opposition

May 3, 2022

Goods & Services

Providing educational programs in the life science fields using on-line activities, non-downloadable webinars and blogs, workshops, and printable materials distributed therewith featuring Regulatory issues and developments, GxP (Good Practice) Compliance, Risk Management, Design Control, QMS (Quality Management Solutions), CSV (Computer System Validation), SOP (Standard Operating Procedures), Data Integrity, UDI (Unique Device Identification), Regulatory readiness, and other related practice areas in the life sciences fields

Business advisory, development, and strategic planning services provided to companies for business purposes in the life sciences industries; Business consultation services in the field of GxP (Good Practice) compliance; Business consulting services on processes and workflows related to content creation, localization and publishing strategy including Translation Memory and Terminology Management, Quality Management, Life Sciences Regulatory Compliance and Risk Management; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology with governmental regulatory bodies around the world; Regulatory submission management, namely, providing simultaneous multiple country submissions of applications for the registration and approval of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; providing information online regarding regulatory submission management; Business management consulting, strategic planning and business advisory services provided to medical, medical technology, biopharmaceutical, and biotechnology companies, and government agencies, educational and research institutions, law firms, and investment firms in the fields of biologics, pharmaceuticals and medical devices; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug and medical device approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and medical devices with governmental regulatory bodies; Business consulting services in the field of biologics, pharmaceuticals, prescription drugs and medical devices; Business consulting and management for companies in the life sciences fields pertaining to business operations including standard operating procedures, audits and assessments; Business consulting and for companies in the life sciences fields related to supply chain management, including, internet of medical things (IoMT), connected service and quality management, product lifecycle management, product master management, and enterprise resource planning; Providing IT staffing services for companies in the life sciences fields and employment consultation pertaining to staffing augmentation services and onsite and remote on-demand compliance staff augmentation; Business consulting and management for companies in the life sciences fields pertaining to business operations including information and data compiling and analyzing relating to business management; consulting services in the field of medical device product approval for commercial purposes

Regulatory compliance consulting services in the life sciences fields, namely, reviewing standards and practices to assist clients with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; providing technical regulatory affair consulting services directed to medical, medical technology, biopharmaceutical, and biotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; and regulatory compliance consulting in the fields of biologics, pharmaceuticals, prescription drugs and medical device

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; biotechnology research consulting services; pharmaceutical research and product development for use in manufacturing; information technology consultation services; computer aided design services; Consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; product research and development for others in the fields of biologics, pharmaceuticals, prescription drugs and medical devices; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biologics, pharmaceuticals, prescription drugs and medical devices; scientific consulting and research services relating to the field of pharmaceuticals, medical devices, and life sciences, namely, biology, and medicine; design and development and technical verification consulting services in the fields of biotechnology and pharmaceutical research, and scientific and technological services, namely, scientific research, analysis, testing, and related scientific studies in the field of chemistry and molecular biology, namely, biologics and protein detection, characterization, analysis and testing; Computer consulting services in the field of cloud computing in the field of life science; Technical and scientific research consulting and computer project management for companies in the life sciences fields pertaining to cloud-based data migration; Technical and scientific consulting and management for companies in the life sciences fields pertaining to technical verification and validation laboratory equipment and instrumentation; Technical and scientific consulting and management for companies in the life sciences fields for digital purposes, including digital compression of computer data; Technical and scientific consulting and management for companies in the life sciences fields for cloud computing purposes, including GxP (Good Practice) cloud seeding services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 19, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 19, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 13, 2022 NONP
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Apr 1, 2022 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2022 CNSA
USE AMENDMENT ACCEPTED
Mar 31, 2022 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Mar 30, 2022 AUPC
USE AMENDMENT FILED
Mar 30, 2022 IUAF
TEAS AMENDMENT OF USE RECEIVED
Mar 29, 2022 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 27, 2022 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 20, 2021 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 8, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 5, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
May 5, 2021 GNSL
SUSPENSION LETTER WRITTEN
May 5, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 15, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 15, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 15, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2020 NWOS
NEW APPLICATION ENTERED
Jul 2, 2020 NWAP